×
模态框(Modal)标题
在这里添加一些文本
Close
Close
Submit
Cancel
Confirm
×
模态框(Modal)标题
×
导航切换
Journal of International Oncology
Home
About Journal
About Journal
Journal History
Objective
Editorial Committee
Editorial Boards
Communications Editorial Board
Introduction to Editor-in-Chief
General Principles of the Editorial Board
Guide for Authors
Online Submission Guide
Instructions for Authors
Publication Ethics
Aim and Scope
Subscribe
Contacts Us
中文
Clinical efficacy of S-1 combined with gefitinib in the treatment of advanced NSCLC with EGFR-TKI acquired drug resistance
Shen Jingxia, Han Bin, Wang Shuying, Kang Haili, Wang Lidong, Liu Xuhui, Cui Qinggui
Journal of International Oncology . 2019, (
12
): 723 -727 . DOI: 10.3760/cma.j.issn.1673-422X.2019.12.004